We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Pfizer, DISH Network, Micron Technology, Walt Disney and C.H. Robinson
Read MoreHide Full Article
For Immediate Release
Chicago, IL –October 3, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Pfizer (PFE - Free Report) , DISH Network , Micron Technology (MU - Free Report) , The Walt Disney Company (DIS - Free Report) and C.H. Robinson Worldwide (CHRW - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Analyst Reports for Pfizer, DISH and Micron
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Pfizer, DISH Network and Micron Technology. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Pfizer’s shares have underperformed the Zacks Large-Cap Pharmaceuticals industry in the past six months (-16.3% vs. -4.7%). The Zacks analyst believes that the Consumer Healthcare joint venture with Glaxo, the Array acquisition and the pending merger of Upjohn unit with Mylan, if successful, will make Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
The smaller Pfizer should see better revenue growth as the Lyrica loss of exclusivity cliff will go away. Pfizer expects continued strong growth of key brands like Ibrance and Eliquis and biosimilars to drive sales in the second half.
However, currency headwinds, Lyrica LOE, weak sales in the sterile injectables portfolio and pricing pressure are top-line headwinds in 2019. Moreover, unfavorable changes in recommendation guidelines for Prevnar 13 and unfavorable FDA updates to the Xeljanz U.S. label may hurt sales of these key drugs in the second half.
Shares of DISH Network have gained 36.4% year to date, outperforming the Zacks Cable Television industry’s rise of 30.5% over the same period. The Zacks analyst believes that DISH is suffering from subscriber loss in the Pay-TV business, primarily due to stiff competition and cord-cutting.
Also, increasing programming and content expenses as well as higher retransmission fees are hurting profitability. Nevertheless, the company’s efforts to diversify its business from being a pure-play satellite-TV operator to an Internet TV operator are noteworthy. Sling TV subscriber base is also expanding, which is a positive.
Further, the company’s focus on acquiring and retaining subscribers, to boost profits over the long term, is expected to drive growth. Further, DISH announced that it will enter the U.S. wireless market as the fourth, nationwide, facilities-based network competitor.
Micron’s shares have gained 8.2% in the past three months, outperforming the Zacks Semiconductors industry’s rise of 3.7%. The Zacks analyst believes that the company is well-poised to benefit from the resurgence in DRAM demand, backed by a progress in customer inventory adjustments in the cloud, graphics and PC markets.
Moreover, its focus on increasing the mix of high-value solutions in its portfolio is a boon. Further, introduction of server processors that supports higher memory densities is likely to fuel demand for its solutions. Also, the company’s decision to cut down on capital expenditure will enable it to reach a balanced inventory level.
However, a higher mix of NAND, which has lower gross margin, falling memory prices and a slow decline in manufacturing cost, is likely to keep margins under pressure. Uncertainty hovering over trade and the economy is a concern as well.
Other noteworthy reports we are featuring today include The Walt Disney Company and C.H. Robinson Worldwide.
Free: Zacks’ Single Best Stock Set to Double
Today you are invited to download our just-released Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press releas
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Pfizer, DISH Network, Micron Technology, Walt Disney and C.H. Robinson
For Immediate Release
Chicago, IL –October 3, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Pfizer (PFE - Free Report) , DISH Network , Micron Technology (MU - Free Report) , The Walt Disney Company (DIS - Free Report) and C.H. Robinson Worldwide (CHRW - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Analyst Reports for Pfizer, DISH and Micron
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Pfizer, DISH Network and Micron Technology. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Pfizer’s shares have underperformed the Zacks Large-Cap Pharmaceuticals industry in the past six months (-16.3% vs. -4.7%). The Zacks analyst believes that the Consumer Healthcare joint venture with Glaxo, the Array acquisition and the pending merger of Upjohn unit with Mylan, if successful, will make Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
The smaller Pfizer should see better revenue growth as the Lyrica loss of exclusivity cliff will go away. Pfizer expects continued strong growth of key brands like Ibrance and Eliquis and biosimilars to drive sales in the second half.
However, currency headwinds, Lyrica LOE, weak sales in the sterile injectables portfolio and pricing pressure are top-line headwinds in 2019. Moreover, unfavorable changes in recommendation guidelines for Prevnar 13 and unfavorable FDA updates to the Xeljanz U.S. label may hurt sales of these key drugs in the second half.
Shares of DISH Network have gained 36.4% year to date, outperforming the Zacks Cable Television industry’s rise of 30.5% over the same period. The Zacks analyst believes that DISH is suffering from subscriber loss in the Pay-TV business, primarily due to stiff competition and cord-cutting.
Also, increasing programming and content expenses as well as higher retransmission fees are hurting profitability. Nevertheless, the company’s efforts to diversify its business from being a pure-play satellite-TV operator to an Internet TV operator are noteworthy. Sling TV subscriber base is also expanding, which is a positive.
Further, the company’s focus on acquiring and retaining subscribers, to boost profits over the long term, is expected to drive growth. Further, DISH announced that it will enter the U.S. wireless market as the fourth, nationwide, facilities-based network competitor.
Micron’s shares have gained 8.2% in the past three months, outperforming the Zacks Semiconductors industry’s rise of 3.7%. The Zacks analyst believes that the company is well-poised to benefit from the resurgence in DRAM demand, backed by a progress in customer inventory adjustments in the cloud, graphics and PC markets.
Moreover, its focus on increasing the mix of high-value solutions in its portfolio is a boon. Further, introduction of server processors that supports higher memory densities is likely to fuel demand for its solutions. Also, the company’s decision to cut down on capital expenditure will enable it to reach a balanced inventory level.
However, a higher mix of NAND, which has lower gross margin, falling memory prices and a slow decline in manufacturing cost, is likely to keep margins under pressure. Uncertainty hovering over trade and the economy is a concern as well.
Other noteworthy reports we are featuring today include The Walt Disney Company and C.H. Robinson Worldwide.
Free: Zacks’ Single Best Stock Set to Double
Today you are invited to download our just-released Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.
Download Free Report Now >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press releas